PH 3
Showing 1 - 25 of >10,000
Oropharyngeal Dysphagia, Dysphagia, Swallowing Disorder Trial in Mataró (Capsaicin 10microM (TRPV1 natural agonist), Piperine
Completed
- Oropharyngeal Dysphagia
- +2 more
- Capsaicin 10microM (TRPV1 natural agonist)
- +5 more
-
Mataró, Barcelona, SpainConsorci Sanitari del Maresme (Hospital de Mataró)
Jul 12, 2022
In Vitro Fertilisation Outcome Trial in Egypt (Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6, Transfer embryo
Active, not recruiting
- In Vitro Fertilisation Outcome
- Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6
- +2 more
-
Assiut, Egypt
- +5 more
Aug 13, 2022
Periodontitis, Periodontal Pocket, Periodontal Diseases Trial in Oslo (4% chitosan gel (pH 3.48)., Reciprocal Chitosan brush)
Not yet recruiting
- Periodontitis
- +3 more
- 4% chitosan gel (pH 3.48).
- Reciprocal Chitosan brush
-
Oslo, NorwayBjerke tannmedisin
Mar 6, 2023
Type 2 Diabetes Trial (behavioral, device, other)
Not yet recruiting
- Type 2 Diabetes
- Acceptance and Commitment Therapy
- +2 more
- (no location specified)
Sep 5, 2023
Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)
Not yet recruiting
- Bullous Pemphigoid
- efgartigimod PH20 SC
- Prednisone
- (no location specified)
Dec 27, 2022
Vaginal Flora Imbalance Trial in Osasco (Stryphnodendron Adstringens 3% - once daily post bath)
Not yet recruiting
- Vaginal Flora Imbalance
- Stryphnodendron Adstringens 3% - once daily post bath
-
Osasco, São Paulo, BrazilMedcin Instituto da Pele
Oct 10, 2023
Hypertension, Pulmonary Trial in Germany, United Kingdom (Blood Sample, Cardiac MRI)
Completed
- Hypertension, Pulmonary
- Blood Sample
- Cardiac MRI
-
Bonn, Germany
- +7 more
Aug 16, 2022
Pulmonary Hypertension Trial in Vienna (Aria CV Acute PH System)
Recruiting
- Pulmonary Hypertension
- Aria CV Acute PH System
-
Vienna, AustriaMedical University of Vienna
Mar 14, 2022
Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)
Enrolling by invitation
- Primary Hyperoxaluria Type 1 (PH1)
- +5 more
-
San Francisco, California
- +19 more
Jun 22, 2022
Myositis Trial (EFG PH20 SC)
Not yet recruiting
- Myositis
- EFG PH20 SC
- (no location specified)
Jul 28, 2023
Stroke, Acute Trial in London (3D CEST imaging)
Recruiting
- Stroke, Acute
- 3D CEST imaging
-
London, United KingdomKing's College Hospital
Apr 4, 2022
SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron
Not yet recruiting
- SARS-CoV-2 Virus
- +2 more
- Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
- +4 more
- (no location specified)
Sep 14, 2022
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
Anastomotic Leak Trial in Canada, Saudi Arabia, United States (NERv's Inline Device)
Recruiting
- Anastomotic Leak
- NERv's Inline Device
-
Cleveland, Ohio
- +5 more
Jan 20, 2023
Calf Muscle Perfusion in Intermittent Claudication by
Recruiting
- Diagnostic Imaging
- +2 more
- MSOT
-
Erlangen, Bavaria, GermanyUniversity of Erlangen-Nuremberg (FAU), Department of Vascular S
Mar 6, 2023
Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)
Not yet recruiting
- Neurogenic Detrusor Overactivity
-
Palo Alto, California
- +11 more
Jan 16, 2023
Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension Trial in Durham (Hyperpolarized 129Xe)
Not yet recruiting
- Interstitial Lung Disease
- +2 more
- Hyperpolarized 129Xe
-
Durham, North CarolinaDuke University Medical Center
Jan 14, 2022
Primary Hyperoxaluria Type 3 Trial in Worldwide
Recruiting
- Primary Hyperoxaluria Type 3
-
Boston, Massachusetts
- +12 more
Nov 16, 2021
pH, Hypoxia and Haemodialysis
Recruiting
- End Stage Renal Disease on Dialysis
- blood sample pre, during and post HD
- Non invasive cardiac output assessment
-
Coventry, Warwickshire, United Kingdom
- +1 more
Aug 27, 2021
Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)
Overactive Bladder (OAB), Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron, Placebo)
Recruiting
- Overactive Bladder (OAB)
- Pharmacokinetics of Mirabegron
- Mirabegron
- Placebo
-
Edegem, Belgium
- +34 more
Nov 28, 2022
Advanced Breast Cancer Trial in Beijing (Entinostat, Placebo, Exemestane)
Active, not recruiting
- Advanced Breast Cancer
- Entinostat
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy Medical Sciences
Jul 7, 2021